Graco delivered another clean operating quarter to close the first half of fiscal 2026, with the company posting a modest 3% increase in second-quarter net sales. Adjusted operating earnings rose 11%, lifting to $183.2M for the quarter. The earnings beat reflected a 1-percentage-point expansion in gross margin, helped along by the first wave of tariff refunds that flowed through after the U.S. Supreme Court invalidated certain IEEPA-era duties earlier in the year. Management also used the slow-growth organic period to deploy meaningful capital into a high-quality, Industrial-adjacent asset through the Valco Melton acquisition. The rest of this report examines how that choice squares with the rest of the operating story. The deal is the real news of the quarter, even though it closed just after the period end and is absent from the reported numbers.
The valuation backdrop matters for any judgment here. Graco's shares trade near $77, near the bottom of a fifty-two week range that brackets about $95.70 at the high end. The range low is roughly $72.50. The company carries a market capitalization close to $12.5B against a clean balance sheet. Trailing earnings leave the stock at about 24 times reported earnings, and forward earnings pull that multiple to roughly 22. These levels are full by historical standards but easier to defend on the basis of segment margins and the closing acquisition than on the modest organic growth posted in the quarter. The $1.18 annualized dividend yields about 1.5% and provides a credible floor for total return while the market waits for Industrial-segment volumes to recover.
The single forward variable to watch is whether Industrial-segment finishing-system sales normalize in the second half and whether Valco Melton integrates cleanly into the Industrial segment after the late-August close. Management's Q3 sales guide runs from $580M to $600M, and that range excludes the acquired business. Valco Melton generated about $145M of revenue in 2025, so the underlying business is recovering at a glacial pace while the deal adds the next leg of growth almost mechanically. Investors looking for a sharp acceleration in organic growth are unlikely to find one here. Investors looking for evidence that the operating model still converts modest top-line gains into outsized margin and free cash flow should find plenty to work with.